Ahmed, A., Abd Alrahman, H., Esmaiyl, A., Basha, M. (2023). Study of Validity of O-RADS Ultrasonography in Risk Stratification and Management of Adnexal Masses. The Egyptian Journal of Hospital Medicine, 90(1), 1570-1578. doi: 10.21608/ejhm.2023.282508
Asmaa Samir Abd Elsamiaa Ahmed; Hossam Aldin Mansour Abd Alrahman; Ahmad Abd Elazim Esmaiyl; Mohammad Abd Alkhalik Basha. "Study of Validity of O-RADS Ultrasonography in Risk Stratification and Management of Adnexal Masses". The Egyptian Journal of Hospital Medicine, 90, 1, 2023, 1570-1578. doi: 10.21608/ejhm.2023.282508
Ahmed, A., Abd Alrahman, H., Esmaiyl, A., Basha, M. (2023). 'Study of Validity of O-RADS Ultrasonography in Risk Stratification and Management of Adnexal Masses', The Egyptian Journal of Hospital Medicine, 90(1), pp. 1570-1578. doi: 10.21608/ejhm.2023.282508
Ahmed, A., Abd Alrahman, H., Esmaiyl, A., Basha, M. Study of Validity of O-RADS Ultrasonography in Risk Stratification and Management of Adnexal Masses. The Egyptian Journal of Hospital Medicine, 2023; 90(1): 1570-1578. doi: 10.21608/ejhm.2023.282508
Study of Validity of O-RADS Ultrasonography in Risk Stratification and Management of Adnexal Masses
Background: It is important to remember that ovarian cancer is a frequent and potentially fatal disease. For the purpose of characterizing the imaging properties of adnexal masses, the Ovarian-Adnexal Reporting and Data System (O-RADS) Committee have been established. Objective: The aim of the current work was to evaluate the validity of O-RADS to diagnose adnexal masses utilizing pelvic ultrasound. Subjects and methods: This prospective cohort study included a total of 30 women having at least one adnexal mass detected by US, recruited from Department of radiodiagnosis, Zagazig University Hospitals. Results: About 75.8% of the adnexal masses were benign and 24.2% were malignant. The most frequent benign lesion among patients who had O-RADS 2 or 3 was a hemorrhagic cyst. Only 2 patients with O-RADS 5 had benign lesions (mucinous cystadenoma and serous cystadenoma), while 5 patients had malignant lesions.Regarding only those adnexal masses classified as O-RADS 5 to predict adnexal masses malignancy, the O-RADS had a specificity, sensitivity, PPV, NPV and accuracy of 92%, 62.5%, 71.4%, 88.5%, and 84.8%, respectively. Considering combined O-RADS 4 and 5 as a malignancy predictor of adnexal masses, the specificity, sensitivity, PPV, NPV, and accuracy were 72%, 87.5%, 50%, 94.7%, and 75.8%, respectively. Conclusion: It could be concluded that the U/S O-RADS classification system is a great noninvasive diagnostic tool for suspected ovarian masses with high sensitivity in differentiating between benign and malignant neoplastic tumors.
View on SCiNiTO
Top